DNTH

Dianthus Therapeutics INC

+$3.2B

Net Activity

Institutions Holding

243

Popularity Rank

#2443

Avg Weight

0.65%

Total Value

$5.2B

Ownership Trend

243 institutions currently hold DNTH, with 175 net buyers and 75 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Increased

Based on recent trading activity

Net Selling Institutions

75

Net Buying Institutions

175

Key Holders

View all 243 holding institutions

Quarterly Activity

Recent Activity

+$3.7B

Total Buy Value

$723.3M

Total Sell Value

New buy92
Trim56
Add83
Sold out19

175

Net Buyers

75

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

2

Filings (90d)

$5.43M

Total Est. Value

61K shares

Planned Shares

Last Filed 2026-07-09
FilerFiling DateEst. Value
RYAN SAVITZ2026-07-09$3.06M
Veness Adam M2026-06-17$2.37M

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding DIANTHUS THERAPEUTICS INC (DNTH)?
Major stakeholders currently include FMR LLC ($651.9M), BlackRock, Inc. ($266.5M), Ra Capital Management, L.p. ($219.2M). Based on the latest 13F filings, there are a total of 243 tracked investment funds and institutions maintaining positions in DNTH.
What is the overall institutional sentiment toward DNTH recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $3.2B, driven by 175 managers accumulating shares while 75 reduced their exposure.
Which institutions have been selling or reducing their DNTH positions?
In the latest period, 56 funds trimmed their holdings, and 19 managers completely exited their positions. The aggregate reported sell value was $723.3M.
Are there any notable investors adding DNTH to their portfolios?
Yes, buying activity remains notable. 92 institutions opened new positions in {ticker}, and 83 existing holders added to their shares. The total reported buy value for the quarter amounted to $3.7B.

Related Stocks